Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kate Bingham currently holds 38,708 shares of BICYCLE THERAPEUTICS plc (BCYC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kate Bingham has been a net buyer of BCYC stock. They have purchased $5.4M and sold $3.1M worth of shares.
Kate Bingham's most recent insider trade was on Jul 14, 2021, when they sold 917 shares at $34.01 per share.
Kate Bingham serves as Executive at BICYCLE THERAPEUTICS plc (BCYC). They have executed 14 insider transactions totaling $8.5M over their tenure at the company.
Kate Bingham holds the position of Executive at BICYCLE THERAPEUTICS plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Kate Bingham has shown a buying trading pattern, with $5.4M in total purchases and $3.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kate Bingham was on May 28, 2019, when they purchased $5.3M worth of BCYC shares. This transaction involved 377,732 shares at $14.00 per share.
Kate Bingham currently owns 38,708 shares of BICYCLE THERAPEUTICS plc (BCYC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kate Bingham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kate Bingham has 14 Form 4 filings on record as an insider at BICYCLE THERAPEUTICS plc.
Set alerts for Kate Bingham and 40,000+ other insiders.